Teva and Launch Therapeutics collaborate for dual-action asthma rescue inhaler respiratory program

Apr 1, 2024 10:40 pm | News

  • Teva Pharmaceutical (NYSE:TEVA) and Launch Therapeutics announced agreement to further accelerate the clinical research program of Teva’s ICS-SABA.
  • Teva and Abingworth, part of global investment firm Carlyle (NASDAQ: CG), also announced development funding agreement in which Abingworth provides Teva

feed from seekingalpha.com